Our company was founded on January 22, 2015, and the initial capital was NT$40 million, Because of the rapid addition of clinical experimental business and R & D investment, the number of initial capital increases up to NT$355.9 million. Moreover, in recent days, the number of the employees grows from 5 people to 20 people,including( 3 Ph.D. and 14 MSc).